Table 2. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio (N=116).
Variable | Mean ± SD | Median (range) |
---|---|---|
Neutrophil to lymphocyte ratio | ||
Node negative | 2.22±1.41 | 1.78 (0.23–8.20) |
Node positive | 5.95±3.69 | 5.32 (2.27–17.80) |
Metastatic disease | 6.51±6.57 | 4.51 (2.34–36.00) |
Combined† | 6.18±5.06 | 4.69 (2.27–36.00) |
Platelet to lymphocyte ratio | ||
Node negative | 126.19±46.86 | 123.03 (14.00–257.69) |
Node positive | 278.04±169.54 | 241.54 (105.45–957.14) |
Metastatic disease | 290.82±352.40 | 196.85 (106.38–2,185.18) |
Combined† | 283.38±259.95 | 212.42 (105.45–2,185.18) |
†, combined equals metastatic disease and node positive patients.